Delivery Order SPE2DR25D1202-SPE2DR26F74HE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,511.28 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalation powder (60-count units) on January 8, 2026. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 9, 2026. The award represents a task order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $16,366.12 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of TRELEGY ELLIPTA 200-62.5-25 inhalation powder (60-dose units). This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of January 13, 2026, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order executed under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in a 60-dose configuration. This $3,552.68 firm fixed-price delivery order, which is not set-aside restricted, represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $18,871.26 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 9, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in 60-dose units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 12, 2026. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder in a 60-dose configuration, with a ceiling value of $13,819.64. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $25,562.32 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder with a 60-dose capacity. This firm fixed-price, competitively awarded delivery order is set to be completed by January 14, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating full and open...
- The Defense Logistics Agency awarded a delivery order valued at $30,319.82 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price, non-set-aside delivery order was awarded on January 30, 2026, with an ultimate completion date of February 2, 2026. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $36,826.86 to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $9,271.35 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalation powder (60-count supply) on January 6, 2026, with completion expected by January 7, 2026. This is a firm fixed-price delivery order issued under a competitive process with no set-aside designation. The award leverages AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $11,097.32 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for Trelegy Ellipta 100-62.5-25 inhalers (60-count supply). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 23, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F74HEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,398.07 to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in a 60-dose configuration. This competitive, firm fixed-price delivery order has an ultimate completion date of January 30, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order execution under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal military and veteran healthcare systems. The company maintains significant contract vehicles with the Defense Logistics Agency and other federal agencies to supply prescription medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Trelegy Ellipta, a combination respiratory medication used in chronic obstructive pulmonary disease management, reflects the company's ongoing role as a critical vendor supporting military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 1/28/26 |